Enquiry/Quote
Doxofylline Syrup bulk supplier for pharma manufacturers

Doxofylline Syrup Suppliers & Bulk Manufacturers

Available Forms: Oral Syrup

Available Strengths: 100 mg/5 ml, 200 mg/5 ml,

Reference Brands: Doxolin (India), Doxofyl (India/LATAM)

Category: Respiratory Disorder

Doxofylline is a methylxanthine derivative used in chronic obstructive pulmonary disease, asthma, and bronchospasms. Doxofylline Syrup is available in Oral Syrup and strengths such as 100 mg/5 ml, 200 mg/5 ml,. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doxofylline Syrup is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Technical Specifications & Supply Details
Lead Time 7 to 60 days (depending on batch size & schedule)
MOQ As per manufacturer’s batch size
COA Available with every batch
Regulatory Dossier / DMF Available upon request
Export Documentation FSC, COA, Manufacturing License, Product Permission
Standards IP, BP, USP
Certifications WHO-GMP, EU-GMP, USFDA (as applicable)

Doxofylline Syrup can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Doxofylline is a xanthine-derived bronchodilator used in the management of chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and bronchiectasis. It works by relaxing the smooth muscles of the airways, leading to bronchodilation and improved airflow, thereby helping patients breathe more easily. Doxofylline has been widely studied and is considered to have comparable efficacy to theophylline in controlling respiratory symptoms, but with a significantly improved safety profile and fewer side effects, particularly related to the cardiovascular and central nervous systems.

This makes it a preferred alternative in many clinical settings where long-term bronchodilator therapy is required. In addition to asthma and COPD, doxofylline has shown potential benefits in the treatment of bronchiectasis, and in 2014, it received orphan drug designation from the US Food and Drug Administration (FDA) for this indication. The drug is generally well tolerated, with mild side effects such as nausea, headache, or gastrointestinal discomfort reported in some patients. It is available in various dosage forms including tablets and syrups and is widely used across global markets for effective respiratory care.

Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Doxofylline is used for the treatment and management of respiratory conditions such as bronchial asthma, chronic obstructive pulmonary disease (COPD), and other diseases associated with bronchospasm.

Doxofylline is a synthetic xanthine derivative that acts as a bronchodilator by relaxing the smooth muscles of the airways.

It is marketed under various trade names such as Doxolin Syrup, Doxofyl Syrup, Doxotab Syrup, and other regional brands.

It is manufactured by multiple pharmaceutical companies including Cipla, Lupin, Glenmark, and several other generic manufacturers worldwide.

The generic name is Doxofylline.

Common brand names include Doxolin, Doxofyl, Doxotab, and other region-specific brands.

Doxofylline syrup is primarily manufactured in India and also produced in other regions such as Europe, Latin America, and Southeast Asia by various pharmaceutical companies.

Yes, Doxofylline Syrup is available with DMF and other regulatory documents such as COA and MSDS. These can be provided upon request for qualified buyers.

Absolutely. Sample requests are accepted for formulation trials and quality checks. Please submit an enquiry to initiate the process.

Our manufacturing partners are GMP-certified and comply with ISO and WHO standards, ensuring global quality benchmarks.

Lead times vary based on quantity and destination, but most orders are fulfilled within 1–3 weeks. Express shipping options are available.

Yes, Doxofylline Syrup is exported to over 30 countries across Asia, Africa, Europe, and Latin America. We support documentation for customs and regulatory clearance.

Related Products

Salmeterol Xinafoate

Strength:
25 µg, 50 µg

Form: Inhalation

Reference Brands: Serevent (USA/LATAM/EU)

View Details
Formoterol Fumarate

Strength:
12 µg

Form: Inhalation

Reference Brands: Foradil (USA/LATAM), Oxis (India)

View Details
Ethionamide

Strength:
250 mg

Form: Tablets

Reference Brands: Generic formulations marketed under different names

View Details
Olodaterol

Strength:
2.5 mcg

Form: Inhalation solution

Reference Brands: Striverdi Respimat (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.